The North America Ophthalmoscopes Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
Innovations in technology and the developing of superior products will optimize the industry's use of ophthalmoscope equipment even further. Scanning laser ophthalmoscopes have been in the market for decades, but the recent surge in demand and supply of numerous advantages has given the market a new path. As a result, scanning laser ophthalmoscopes have made major advancements in recent years.
These ophthalmoscopes may obtain images with a greater view of the ocular fundus while keeping a high level of resolution, hence increasing the number of eye examinations that can be performed. In addition, they are preferable to traditional fundoscopy due to their capacity to image aberrant choroid and retinal changes. A thorough eye exam is essential to accurately identify eye conditions. Ophthalmoscopy is a procedure performed during an eye test using an ophthalmoscope to examine the fundus of the eye.
Ophthalmoscopes focus a narrow beam of light through the pupil of the patient's eye, allowing for the detection of anomalies in the lens, optic disc, vitreous fluid, and retina. Ophthalmoscopes comprise a light source, battery handle, eyepiece, and aperture selector. In addition, ophthalmoscopes now include acquiring, storing, and sharing fundus images, improving the ophthalmological process and ophthalmoscopes' business potential.
More than three million People have glaucoma, according to the CDC. 1 This figure is projected to increase to 6,300,000 by the year 2050. 2 In terms of direct expenditures and lost productivity, glaucoma costs the US economy $2.86 billion annually. More than 4.2 million Americans aged 40 and older are legally blind or have low vision (best-corrected visual acuity less than 6/12 (20/40) in the better-seeing eye). In the United States, the major causes of low vision and blindness are predominantly age-related eye illnesses. In 2019, approximately one-fifth (17.5%) of Canada's population comprised seniors, accounting for 6,6 million individuals. So, it is anticipated that the ageing population and high frequency of eye-related diseases will contribute to the rise of ophthalmoscopes in the North American region.
The US market dominated the North America Ophthalmoscopes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $84.8 Million by 2028. The Canada market is poised to grow at a CAGR of 8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, Others. Based on Type, the market is segmented into Direct and Indirect. Based on Application, the market is segmented into Glaucoma, Diabetic Retinopathy, Macular Degeneration, Retinal Repair and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Ophthalmoscopes Market is Predict to reach $332.9 Million by 2028, at a CAGR of 6.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hill-Rom Holdings, Inc. (Welch Allyn) (Baxter International, Inc.), Keeler Ltd. (Halma Plc), Zumax Medical co. ltd, Albert Waeschle Limited, Neitz Instruments Co., Ltd., Iridex Corporation, HEINE Optotechnik GmbH & Co. KG, HONSUN Group, Nidek Co., Ltd., and Suzhou KangJie Medical, Inc.
By End-Use
By Type
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
